HomeOwner Search
Visit USCO2008
Category SearchPHARMACEUTICAL LAW: REGULATION OF RESEARCH, DEVELOPMENT, AND MARKETING
![hero image](/_next/image?url=%2Fimages%2FCRLogo.png&w=384&q=75)
Text Registration
Copyright Title
PHARMACEUTICAL LAW: REGULATION OF RESEARCH, DEVELOPMENT, AND MARKETING
Status
Published
on 24 Jul 2008
Year of Creation
2007
Copyright Claimant
AMERICAN BAR ASSOCIATION
Registration Number
TX0007108521
on 24 Jul 2008Copyright Summary
The U.S. Copyright record (Registration Number: TX0007108521) dated 24 Jul 2008, pertains to an electronic file (eService) titled "PHARMACEUTICAL LAW: REGULATION OF RESEARCH, DEVELOPMENT, AND MARKETING" created in 2007. The copyright holder is AMERICAN BAR ASSOCIATION, known for their creative contributions in text registration. For any inquiries concerning this copyrighted material, kindly reach out to AMERICAN BAR ASSOCIATION.
Application Details
Registration Number
TX0007108521
Registration Date
7/24/2008
Year of Creation
2007
Agency Marc Code
DLC-CO
Record Status
New
Corporate Author
AMERICAN BAR ASSOCIATION
Physical Description
Book, 853 p
Statements
Application Title Statement: PHARMACEUTICAL LAW: REGULATION OF RESEARCH, DEVELOPMENT, AND MARKETING
Author Statement: ABA, Health Law Section employer for hire Domicile: United States Citizenship: United States
© 2023 reserved by Trademarkia
Show terms & conditions
Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.